| Particulars |
|
|
|
| Company Name
| Evonile Pharma Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
12.35 |
B.V. (₹) |
312.60 |
| Sales(₹ Cr.) |
376.96 |
NP (₹ Cr.) |
93.20 |
| NP Var% |
-8.00 |
Div% |
500.00 |
| CPS(₹) |
38.50 |
EPS (₹) |
37.70 |
| Traded Value(₹ Lakhs) |
30.36 |
52 Week High |
2,588.00 |
| 52 Week Low |
750.00 |
Price BSE |
1,814.00 |
| Price NSE |
1,819.00 |
Market Capital (₹ Cr.) |
4,479.03 |
| P/C Ratio |
47.10 |
P/E Ratio |
48.10 |
| Price Vs.BV |
5.80 |
|
| Latest Quarter |
| Year End |
202609 |
Sales (₹ Cr.) |
56.05 |
| NP(₹ Cr.) |
-9.28 |
NP Var % |
-138.00 |
| Trailing Twelve Months |
| Year End |
202609 |
Sales |
345.11 |
| OPM |
40.91 |
NP |
87.40 |
| NP Var% |
-39.70 |
EPS |
26.03 |
| PE |
69.69 |
|
|